KLHL15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.479800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.358400E-01
Normal-vs-Stage2
4.282600E-01
Normal-vs-Stage3
1.449830E-01
Normal-vs-Stage4
6.863600E-01
Stage1-vs-Stage2
7.483900E-02
Stage1-vs-Stage3
9.455700E-02
Stage1-vs-Stage4
9.429600E-01
Stage2-vs-Stage3
2.951600E-01
Stage2-vs-Stage4
1.635610E-01
Stage3-vs-Stage4
2.098000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.615800E-01
Normal-vs-AfricanAmerican
8.472400E-01
Normal-vs-Asian
7.015600E-02
Caucasian-vs-AfricanAmerican
2.365000E-01
Caucasian-vs-Asian
6.914300E-02
AfricanAmerican-vs-Asian
3.212400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.377000E-01
Normal-vs-Female
6.813000E-01
Male-vs-Female
3.898000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.049600E-01
Normal-vs-Age(41-60Yrs)
9.119000E-01
Normal-vs-Age(61-80Yrs)
3.806600E-01
Normal-vs-Age(81-100Yrs)
5.479800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.652800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.872970E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.013200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.740300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.295300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.695240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.714200E-02
Normal-vs-Daily Drinker
2.640000E-01
Normal-vs-Weekly Drinker
3.822200E-01
Normal-vs-Occasional Drinker
4.684000E-01
Normal-vs-Social Drinker
9.470000E-01
Non Drinker-vs-Daily Drinker
8.325200E-01
Non Drinker-vs-Weekly Drinker
4.090800E-01
Non Drinker-vs-Occasional Drinker
1.909630E-01
Non Drinker-vs-Social Drinker
1.897370E-01
Daily Drinker-vs-Weekly Drinker
6.297400E-01
Daily Drinker-vs-Occasional Drinker
3.912000E-01
Daily Drinker-vs-Social Drinker
2.294400E-01
Weekly Drinker-vs-Occasional Drinker
7.537600E-01
Weekly Drinker-vs-Social Drinker
3.432000E-01
Occasional Drinker-vs-Social Drinker
4.206200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.029800E-01
Normal-vs-Grade 2
1.703610E-01
Normal-vs-Grade 3
1.356810E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.405400E-01
Grade 1-vs-Grade 3
1.823650E-01
Grade 1-vs-Grade 4
2.029800E-01
Grade 2-vs-Grade 3
7.452400E-01
Grade 2-vs-Grade 4
1.703610E-01
Grade 3-vs-Grade 4
1.356810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.318400E-01
Normal-vs-NonDiabetic
4.911800E-01
Diabetic-vs-NonDiabetic
6.322600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.521500E-02
Normal-vs-NoPancreatitis
5.059600E-01
Pancreatitis-vs-NoPancreatitis
2.428100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.911600E-01
Normal-vs-N1
4.643400E-01
N0-vs-N1
5.851800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.177000E-01
Normal-vs-TP53-NonMutant
9.859800E-01
TP53-Mutant-vs-TP53-NonMutant
9.180300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
